Indian pharmaceutical industry set to reach $130 Billion by 2030
The Indian pharmaceutical industry is poised for substantial growth, with projections indicating a compound annual growth rate (CAGR) of over 10% and a size of $130 billion by 2030.
The Indian pharmaceutical industry is poised for substantial growth, with projections indicating a compound annual growth rate (CAGR) of over 10% and a size of $130 billion by 2030.
Shares of Piramal Pharma Ltd. surged more than 13% following the announcement of its first profitable quarter in three quarters.
Psoriasis Research Institute of Guangzhou (PRIG), a subsidiary of iST Pharma, has received approval from the US Food and Drug Administration (FDA) to conduct a Phase III trial of its investigational new drug (IND), TC Cream, for the treatment of psoriasis vulgaris.
Pharmaceutical companies are increasingly embracing artificial intelligence (AI) to expedite the development of new drugs, according to Bloomberg.
Reprocell USA, a contract research organisation (CRO), has been awarded a contract to support Lantern Pharma’s Phase 2 clinical trial for its investigational new drug LP-300 in combination with carboplatin and pemetrexed.
As the pharmaceutical industry continues to rely more heavily on digital technology, the importance of cybersecurity solutions is increasing.
Bayer AG (BAYGn.DE) aims to invest $1 billion in medicinal research and development in the United States this year as part of its efforts to treble its sales in the country by the end of the decade.
Notwithstanding various disruptive occurrences, ICRA forecasts the domestic pharmaceutical business to increase by 6-8 percent in the upcoming fiscal year.
ZavzpretTM (zavegepant) nasal spray, a calcitonin gene-related peptide (CGRP) receptor antagonist, has been authorised by the Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults.
Walgreens has collaborated with DoorDash and Uber to offer Same-Day Rx Delivery, a service that will give free same-day delivery of HIV treatment and prevention drugs.
The Indian pharmaceutical industry is poised for substantial growth, with projections indicating a compound annual growth rate (CAGR) of over 10% and a size of $130 billion by 2030.
Shares of Piramal Pharma Ltd. surged more than 13% following the announcement of its first profitable quarter in three quarters.
Psoriasis Research Institute of Guangzhou (PRIG), a subsidiary of iST Pharma, has received approval from the US Food and Drug Administration (FDA) to conduct a Phase III trial of its investigational new drug (IND), TC Cream, for the treatment of psoriasis vulgaris.
Pharmaceutical companies are increasingly embracing artificial intelligence (AI) to expedite the development of new drugs, according to Bloomberg.
Reprocell USA, a contract research organisation (CRO), has been awarded a contract to support Lantern Pharma’s Phase 2 clinical trial for its investigational new drug LP-300 in combination with carboplatin and pemetrexed.
As the pharmaceutical industry continues to rely more heavily on digital technology, the importance of cybersecurity solutions is increasing.
Bayer AG (BAYGn.DE) aims to invest $1 billion in medicinal research and development in the United States this year as part of its efforts to treble its sales in the country by the end of the decade.
Notwithstanding various disruptive occurrences, ICRA forecasts the domestic pharmaceutical business to increase by 6-8 percent in the upcoming fiscal year.
ZavzpretTM (zavegepant) nasal spray, a calcitonin gene-related peptide (CGRP) receptor antagonist, has been authorised by the Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults.
Walgreens has collaborated with DoorDash and Uber to offer Same-Day Rx Delivery, a service that will give free same-day delivery of HIV treatment and prevention drugs.
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.